The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 10th May 2013 07:14

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation.Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral.Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating unchanged. Deutsche Bank shifts target price from 323p to 336p and reiterates a buy recommendation.British Sky Broadcasting Group: Bank of America cuts target price from 670p to 650p and reiterates an underperform rating.Britvic: Deutsche Bank raises target price from 425p to 460p and retains a hold recommendation.BT Group: Bank of America takes target price from 275p to 325p and upgrades to buy.Clarke T: Panmure Gordon moves target price from 40p to 58p and upgrades from hold to buy.Derwent London: Morgan Stanley increases target price from 2220p to 2450p and upgrades to overweight.e-Therapeutics: Panmure Gordon shifts target price from 72p to 67p keeping its buy recommendation.Experian: Citigroup raises target price from 1320p to 1410p and maintains a buy recommendation. Deutsche Bank downgrades to hold with a target price of 529p.Greencore: Investec shifts target price from 125p to 130p and maintains a buy recommendation. Panmure Gordon takes target price from 110p to 125p retaining its buy recommendation.Inchcape: HSBC Holdings initiates with a target price of 640p and an overweight rating.InterContinental Hotels Group: JP Morgan lowers target price from 1950p to 1920p and reiterates a neutral rating.London Mining: JP Morgan moves target price from 215p to 205p and maintains an overweight rating.Lonmin: Exane BNP lowers target price from 270p to 260p staying with its neutral rating.Morrison (Wm): Nomura ups target price from 270p to 310p keeping a neutral rating.National Grid: JP Morgan moves target price from 730p to 785p and retains a neutral rating.Ocado Group: Goldman Sachs upgrades to buy with its target price at 300p. Panmure Gordon raises target price from 50p to 130p, but still recommends selling.Portmeirion: Panmure Gordon takes target price from 657p to 694p reiterating its buy recommendation.Restaurant Group: Panmure Gordon increases target price from 435p to 560p and keeps a buy recommendation.Rightmove: Panmure Gordon ups target price from 2000p to 2300p and leaves its buy recommendation unchanged.RPC Group: JP Morgan reduces target price from 512p to 491p and stays with its overweight rating.Sage Group: Exane BNP shifts target price from 235p to 240p and leaves its underperform rating unaltered.SIG: JP Morgan raises target price from 95p to 135p, while maintaining an underweight rating.St Modwen Properties: JP Morgan increases target price from 290p to 320p staying with its overweight rating.Travis Perkins: JP Morgan ups target price from 999p to 1380p, while its neutral rating remains unchanged. Panmure Gordon downgrades from buy to hold with a target price of 1350p.TUI Travel: Numis ups target price from 350p to 375p and reiterates an add rating. Panmure Gordon moves target price from 303p to 315p, while its hold recommendation is reiterated.Restaurant Group: Citigroup downgrades to neutral with a target price of 500p.Royal Bank of Scotland: Citigroup lowers target price from 300p to 290p keeping a neutral rating.Wetherspoon (JD): Deutsche Bank takes target price from 490p to 520p and maintains a hold recommendation. Panmure Gordon increases target price from 615p to 738p retaining a buy recommendation.
More News
2 Jul 2021 13:47

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

Read more
9 Jun 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
2 Jun 2021 09:42

E-therapeutics brings in Alison Gallafent as head of IP

(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.

Read more
14 May 2021 14:20

E-therapeutics raises £22.5m to expand capabilities and pipeline

(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.

Read more
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:48

e-Therapeutics raises GBP23 million to expand capability and pipeline

e-Therapeutics raises GBP23 million to expand capability and pipeline

Read more
13 May 2021 17:52

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

Read more
13 May 2021 16:40

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

Read more
13 May 2021 10:29

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Read more
6 May 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Apr 2021 11:31

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

Read more
23 Apr 2021 11:29

e-Therapeutics gets two payments from Galapagos under collaboration

e-Therapeutics gets two payments from Galapagos under collaboration

Read more
23 Apr 2021 10:18

E-therapeutics to receive two milestone payments from Galapagos

(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.

Read more
29 Mar 2021 15:13

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.